|
| 35953526 | European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). | Neuro Oncol | 2023 |
| 36181606 | Emerging systemic treatment options in meningioma. | J Neurooncol | 2023 |
| 35849035 | Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. | Neuro Oncol | 2023 |
| 35953526 | European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). | Neuro Oncol | 2023 |
| 37855895 | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042. | Acta Neuropathol | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 37750955 | Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma. | J Cancer Res Clin Oncol | 2023 |
| 37774317 | RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. | J Clin Oncol | 2023 |
| 37863528 | Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | ESMO Open | 2023 |
| 37477610 | What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib? | Neuro Oncol | 2023 |
| 37345077 | Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study. | Cancers (Basel) | 2023 |
| 37219741 | Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. | Clin Exp Metastasis | 2023 |
| 37279174 | Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. | Neuro Oncol | 2023 |
| 37277265 | Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419). | Eur J Cancer | 2023 |
| 37085569 | Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours. | Nat Rev Clin Oncol | 2023 |
| 36947280 | Brain metastases from hepatopancreatobiliary malignancies. | Clin Exp Metastasis | 2023 |
| 37196399 | Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort. | ESMO Open | 2023 |
| 36632791 | EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. | Neuro Oncol | 2023 |
| 37192696 | Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study. | J Thromb Haemost | 2023 |
| 36562460 | Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana? | Neuro Oncol | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 36470093 | Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study. | Eur J Cancer | 2023 |
| 36989885 | Clinical risk factors for ascites in metastatic pancreatic cancer. | ESMO Open | 2023 |
| 36731326 | Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy. | ESMO Open | 2023 |
| 36980786 | Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer. | Cancers (Basel) | 2023 |
| 37530999 | Correction to: Screening for colorectal cancer. | Wien Klin Wochenschr | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37036472 | Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. | Clin Cancer Res | 2023 |
| 36843451 | Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. | Neuro Oncol | 2023 |
| 36782325 | Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. | Infect Agent Cancer | 2023 |
| 37863528 | Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | ESMO Open | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37855895 | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042. | Acta Neuropathol | 2023 |
| 37750955 | Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma. | J Cancer Res Clin Oncol | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 37774317 | RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. | J Clin Oncol | 2023 |
| 37530999 | Correction to: Screening for colorectal cancer. | Wien Klin Wochenschr | 2023 |
| 35849035 | Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. | Neuro Oncol | 2023 |
| 37192696 | Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study. | J Thromb Haemost | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 37219741 | Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. | Clin Exp Metastasis | 2023 |
| 37085569 | Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours. | Nat Rev Clin Oncol | 2023 |
| 36989885 | Clinical risk factors for ascites in metastatic pancreatic cancer. | ESMO Open | 2023 |
| 36947280 | Brain metastases from hepatopancreatobiliary malignancies. | Clin Exp Metastasis | 2023 |
| 37345077 | Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study. | Cancers (Basel) | 2023 |
| 36980786 | Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer. | Cancers (Basel) | 2023 |
| 37279174 | Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. | Neuro Oncol | 2023 |
| 37277265 | Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419). | Eur J Cancer | 2023 |
| 37036472 | Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. | Clin Cancer Res | 2023 |
| 37477610 | What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib? | Neuro Oncol | 2023 |